Interstitial Cystitis Drugs Market Size And Forecast

Interstitial Cystitis Drugs Market size was valued at USD 1,183.30 Million in 2020 and is projected to reach USD 1,794.83 Million by 2028, growing at a CAGR of 5.38% from 2021 to 2028.

The high prevalence of interstitial cystitis is driving the global Interstitial Cystitis Drugs Market. The advent of gene therapy is positively impacting the global market. Moreover, these drugs are expensive and cause many side effects. This is encouraging companies to establish innovative treatment options such as regenerative therapy and gene therapy as these drugs cause lesser side effects compared to the conventional off-label drugs already available in the market. The Global Interstitial Cystitis Drugs Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Interstitial Cystitis Drugs Market Definition

Interstitial cystitis (IC), also known as painful bladder syndrome, is a chronic bladder issue often associated with bladder pressure and pain, with occasional pain in either the lower abdomen, pelvic, or lower back. The patient could experience pain ranging from mild to severe. The pelvic nerve signal to the brain gets mixed up in an individual suffering from interstitial cystitis. Consequently, an urgency to urinate, often in a small volume, is observed. On average, a person urinates seven times a day; however, in severe cases of IC, urination may occur around 40-60 times a day. IC is not an infection but is often mistaken to be a bladder infection. Factors contributing to interstitial cystitis are: a defect of the epithelium layer of the bladder, leaking epithelium allows toxic agents in urine to irritate the bladder wall.

The treatment of interstitial cystitis consists of oral therapy and intravesical therapy as the first- and second-line treatment options, respectively. However, no single treatment works for all people with the disease. The treatment is based on the symptoms of each patient. Most of the patients try different treatments (or combinations of treatments) to get rid of the symptoms.

Get | Download Sample Report @ https://www.verifiedmarketresearch.com/download-sample?rid=62441&utm_source=Free&utm_medium=004

Currently, the global Interstitial Cystitis Drugs Market has only two approved drugs, ELMIRON and RIMSO-50 (dimethyl sulfoxide). These drugs are proven their efficacy over the symptomatic treatments. However, these drugs are expensive. Therefore, many patients use off-label drugs largely to relieve the symptoms of the disease.

Global Interstitial Cystitis Drugs Market Overview

The high prevalence of interstitial cystitis is driving the global Interstitial Cystitis Drugs Market. The advent of gene therapy is positively impacting the global market. Most of the approved and off-label drugs for interstitial cystitis are small molecules, which cannot completely cure the disease, have side effects on the patients, and are expensive.

Patients suffering from interstitial cystitis experience symptoms such as lower urinary tract issues and bladder pain. Women are highly affected by this condition. This condition is associated with various comorbidities such as endometriosis, fibromyalgia, and allergies. The increasing number of interstitial cystitis cases is driving the demand for interstitial cystitis drugs.

Owing to the disadvantages of available drugs for interstitial cystitis, companies are developing innovative treatment options such as, regenerative therapy and gene therapy that have fewer side effects. The development of such therapies will drive demand. Thus, the high prevalence of interstitial cystitis coupled with the advent of gene therapy will drive the Interstitial Cystitis Drugs Market size growth during the forecast period.

The major challenge for Interstitial Cystitis is that though there are several types of treatment available, no one treatment is universally acceptable. The lack of FDA approval for drugs is a major restraining factor for the Global Interstitial Cystitis Drugs Market. However, the IC drugs market is currently weak due to limitations regarding the efficacy and compliance of available products. Other factors include limited approved treatment options, lack of awareness, and need for disease-modifying therapies.

Global Interstitial Cystitis Drugs Market Segmentation Analysis

The Global Interstitial Cystitis Drugs Market is segmented based on Type, Application, and Geography.

Ask For Report Details @ https://www.verifiedmarketresearch.com/product/interstitial-cystitis-drugs-market/?utm_source=Free&utm_medium=004

 Interstitial Cystitis Drugs Market, By Type

• Oral Therapy
• Intravesical Therapy

Based on Type, the market is bifurcated into Oral Therapy, and Intravesical Therapy. Oral Therapy accounted for the largest market share of 56.96% in 2020, with a market value of USD 674.05 Million and is projected to grow at a CAGR of 4.44% during the forecast period. Intravesical Therapy was the second-largest market in 2020, valued at USD 509.25 Million in 2020.

Interstitial Cystitis Drugs Market, By Sales Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Based on the Sales Channel, the market is bifurcated into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies accounted for the largest market share of 67.69% in 2020, with a market value of USD 800.99 Million and is projected to grow at a CAGR of 4.52% during the forecast period. Retail Pharmacies was the second-largest market in 2020, valued at USD 309.48 Million in 2020.

Interstitial Cystitis Drugs Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

On the basis of Geography, the Global Interstitial Cystitis Drugs Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market share of 37.06% in 2020, with a market value of USD 438.47 Million, and is projected to grow at a CAGR of 4.81% during the forecast period. Europe was the second-largest market in 2020, valued at USD 341.04 Million in 2020.

Key Players

The “Global Interstitial Cystitis Drugs Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Pfizer, Johnson & Johnson, Kyorin Pharmaceutical, UCB Pharma, Astellas Pharma, Bayer, Eli Lilly, Lipella Pharmaceuticals, Seikagaku Corporation, and Grünenthal. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

For More Information @ https://www.verifiedmarketresearch.com/download-sample?rid=62441&utm_source=Free&utm_medium=004

About us –

Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. VMR offers insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.

We, at Verified Market Research assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.

Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research

US: +1 (650)-781-4080

UK: +44 (753)-715-0008

APAC: +61 (488)-85-9400

US Toll-Free: +1 (800)-782-1768

Website:-https://www.verifiedmarketresearch.com/

Email: [email protected]

 

Try Our New Dashboard :-https://www.verifiedmarketresearch.com/dashboard/?utm_source=Free&utm_medium=004